Anika Therapeutics | Eigenkapital Und Reserven



Equity Capital And Reserves Veränderung Datum
Abbott USD 49.06B 9.04B 2025-03
Agios Pharmaceuticals USD 1.47B 74.43M 2025-03
Arrowhead Research USD 684.22M 631.64M 2025-03
Halozyme Therapeutics USD 482.27M 118.45M 2025-03
Insmed USD 99.16M 186.22M 2025-03
Integra LifeSciences USD 1.52B 21.14M 2025-03
J&J USD 78.11B 6.62B 2025-03
Ligand Pharmaceuticals USD 795.53M 34.9M 2025-03
MacroGenics USD 116.06M 4.01M 2024-12
Merit Medical Systems USD 1.43B 49.06M 2025-03
Sanofi 74.07B 3.78B 2025-03
Smith & Nephew USD 5.26B 60M 2024-12
Stryker USD 20.93B 296M 2025-03
Veracyte USD 1.19B 18.97M 2025-03
Xencor USD 639.87M 37.74M 2025-03
Zimmer Biomet Holdings USD 12.47B 93.4M 2024-12



Anika Therapeutics Eigenkapital Und Reserven - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Jul 2025.